デフォルト表紙
市場調査レポート
商品コード
1478061

自動細胞イメージングシステムの世界市場規模、シェア、成長分析、製品別、エンドユーザー別、用途別、技術別、地域別-産業予測、2024~2031年

Global Automated Cell Imaging System Market Size, Share, Growth Analysis, By Product, By End users, By Application, By Technology, By Region - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
自動細胞イメージングシステムの世界市場規模、シェア、成長分析、製品別、エンドユーザー別、用途別、技術別、地域別-産業予測、2024~2031年
出版日: 2024年05月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

自動細胞イメージングシステムの世界市場規模は、2022年に1,089億米ドルと評価され、2023年の1,183億7,000万米ドルから2031年には2,307億2,000万米ドルに成長し、予測期間中(2024~2031年)のCAGRは8.7%で成長する展望です。

市場はより急速かつ健全な速度で拡大すると予測されます。世界にはかつてないほど多くの慢性患者が存在するからです。また、新薬やワクチンの研究開発への投資が増加していることも、市場の拡大を後押ししています。とはいえ、自動細胞イメージング・システムの市場は、メンテナンス費用が高く、交換部品が不足しているため、思うように拡大していないです。世界的に見ると、北米の比率が最も高いです。医療産業における最先端技術の早期導入が原因です。米国はこのセグメントの主要国です。医療セグメントへの多額の投資により、アジア太平洋は急速に拡大しています。

目次

エグゼクティブサマリー

  • 市場概要
  • 隆盛と衰退

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の危機と限界

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主要市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資の分析
  • 主要成功要因
  • 競合の程度

市場力学と展望

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

自動細胞イメージングシステムの世界市場:製品別

  • 市場概要
  • タイムラプス
  • 共局在
  • その他

自動細胞イメージングシステムの世界市場:エンドユーザー別

  • 市場概要
  • 病院
  • 研究と診断ラボ

自動細胞イメージングシステムの世界市場:用途別

  • 市場概要
  • 生細胞生体イメージング
  • スクリーニング

自動細胞イメージングシステムの世界市場:技術別

  • 市場概要
  • 蛍光
  • 発光
  • 位相コントラスト
  • その他

自動細胞イメージングシステムの世界市場:地域別

  • 市場概要
  • アジア太平洋
  • 欧州
  • 北米
  • 中東・アフリカ
  • ラテンアメリカ

自動細胞イメージングシステムの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Carl Zeiss AG
  • Olympus Corporation
  • GE Healthcare
  • Leica Microsystems GmbH
  • PerkinElmer, Inc.
  • Nikon Corporation
  • Molecular Devices LLC
  • BD Biosciences
  • BioTek Instruments, Inc.
  • Sartorius AG
  • Agilent Technologies, Inc.
  • Tecan Group AG
  • Bruker Corporation
  • Merck KGaA
  • Yokogawa Electric Corporation
  • Hamilton Company
  • Danaher Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
目次
Product Code: SQMIG35J2035

Global Automated Cell Imaging System Market size was valued at USD 108.9 billion in 2022 and is poised to grow from USD 118.37 billion in 2023 to USD 230.72 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The market is anticipated to expand more quickly and at a healthier rate. It is because there are more chronic patients in the world than ever before. The expansion of the market is also being driven by increased investments in research and development of novel medications and vaccines. Nevertheless, the market for automated cell imaging systems is not expanding as quickly as it should due to high maintenance costs and a lack of replacement parts. Globally, North America has the largest proportion. The early adoption of cutting-edge technologies in the healthcare industry is to blame. The United States is the main nation in the area. Due to significant investment in the healthcare sector, the Asia-Pacific area is expanding at a quicker rate.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Automated Cell Imaging System Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Automated Cell Imaging System Market Segmental Analysis

The global automated cell imaging system is categorized on the basis of product, end-user, technology, and region. With respect to segmentation by product, the market is grouped into time lapse, colocalization, and others. In terms of classification by end user, the market is segmented into hospitals, and research and diagnostic laboratories. On the basis of application, the market is segmented into live cell vivo imaging, and screening. Based on technology, the market is classified into fluorescence, luminescence, phase contrast, and others. Geographically, the market is segmented into Asia Pacific, Europe, North America, Middle East & Africa, and Latin America.

Drivers of the Global Automated Cell Imaging System Market

Our body exhibits certain genetic abnormalities as a result of radiation and lifestyle changes. This results in aberrant cell division, which causes tumors. Cancer is also brought on by specific chemicals that are exposed to food, water, and soil. In order to determine the dynamics and activities of telomeric repeat-containing RNA, automated cell imaging methods are also necessary for the development of novel cancer kinds. With the ability to examine digitized microscopic images of malignant cells, automated cell imaging is a novel and increasingly popular method for cellular research.

Restraints in the Global Automated Cell Imaging System Market

When an automated cell imaging system is destroyed, its spare parts must be completely replaced, which comes at a very high cost. It's because there is a supply side shortfall caused by the small number of manufacturers of this product. Additionally, the setup costs are relatively significant. Its operation also necessitates considerable electricity.

Market Trends of the Global Automated Cell Imaging System Market

Large pharmaceutical companies are heavily investing in new technology in an effort to develop new medications and vaccines. In long-term experiments, huge chemical libraries, or both, automated cell imaging methods reduce human error and the amount of time required for human intervention. High-resolution photos are collected and analyzed by the system.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Automated Cell Imaging System Market by Product

  • Market Overview
  • Time Lapse
  • and Colocalization
  • and Others

Global Automated Cell Imaging System Market by End users

  • Market Overview
  • Hospitals
  • Research and Diagnostic Laboratories.

Global Automated Cell Imaging System Market by Application

  • Market Overview
  • Live Cell Vivo Imaging
  • and Screening.

Global Automated Cell Imaging System Market by Technology

  • Market Overview
  • Fluorescence
  • Luminescence
  • Phase Contrast
  • and Others

Global Automated Cell Imaging System Market by Region

  • Market Overview
  • Asia Pacific
  • Europe
  • North America
  • Middle East & Africa
  • and Latin America

Global Automated Cell Imaging System Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Leica Microsystems GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTek Instruments, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tecan Group AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yokogawa Electric Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments